References in periodicals archive ?
The Multicenter Automatic Defibrillator Implantation Trial (MADIT) II, sponsored by Guidant, demonstrated that ICD therapy reduced overall mortality by 31 percent in patients who had experienced a previous heart attack and had an ejection fraction of less than or equal to 30 percent.
As previously reported, patients in both the 500 milligram and 2000 milligram groups exhibited significantly greater (p less than or equal to 0.
35 micron design rules; oxide loss of less than 40 angstroms; minimal profile microloading of less than plus or minus one degree; critical dimension deltas of less than or equal to 0.